Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03273907 · ClinicalTrials.gov registry record · NA
Post Approval Study of the CyPass System
A NA study, sponsored by Alcon Research.
- Terminated
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT03273907 is a NA study that was terminated before completion, run by Alcon Research. The registered enrollment target is 79 participants.
The verdict
NCT03273907, a NA study, was terminated before completion, sponsored by Alcon Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that the rate of clinically relevant complications associated with CyPass Micro-Stent placement and stability using the CyPass 241-S applier, as determined at 36 months in the postmarket setting, is less than the pre-specified performance target, which is based on experience with the CyPass Model E applier in COMPASS trial TMI-09-01 (NCT01085357).
Interventions
- PROCEDURE Cataract surgery
- DEVICE CyPass Micro-Stent implanted with CyPass 241-S applier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-10-12 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03273907
The ClinicalTrials.gov registry entry for NCT03273907 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cataract surgery is the first listed.
NCT03273907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03273907 about?
NCT03273907 is a clinical study titled "Post Approval Study of the CyPass System". The purpose of this study is to demonstrate that the rate of clinically relevant complications associated with CyPass Micro-Stent placement and stability using the CyPass 241-S applier, as determined at 36 months in the postmarket setting, is less than the pre-specified performance target, which is ...
What is the current status of trial NCT03273907?
This trial is currently terminated. It is a NA study. The enrollment target is 79 participants. The study started on 2017-10-12. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT03273907?
The interventions under investigation include: Cataract surgery (PROCEDURE), CyPass Micro-Stent implanted with CyPass 241-S applier (DEVICE).
Who is sponsoring clinical trial NCT03273907?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.